Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 143241 - 143260 out of 505060 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| Czech Republic | (L01EA03) nilotinib (adm: O) | NILOTINIB ACCORD | 150MG, 150MG CPS DUR 112(4X28) , BLI | Retail price with vat |
$0-0 |
$0-0 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive | AccordHealthcareS.L.U.,Barcelona |
| Czech Republic | (L01EA03) nilotinib (adm: O) | NILOTINIB ACCORD | 200MG, 200MG CPS DUR 112(4X28) , BLI | Retail price with vat |
$0-0 |
$0-0 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive | AccordHealthcareS.L.U.,Barcelona |
| Czech Republic | (L01EX01) sunitinib (adm: O) | SUNITINIB VIPHARM | 12,5MG, 12,5MG CPS DUR 30 , TBC | Retail price with vat |
$0-0 |
$0-0 |
n/a | VipharmS.A.,OżarówMazowiecki |
| Czech Republic | (L01EX01) sunitinib (adm: O) | SUNITINIB VIPHARM | 25MG, 25MG CPS DUR 30 , TBC | Retail price with vat |
$0-0 |
$0-0 |
n/a | VipharmS.A.,OżarówMazowiecki |
| Czech Republic | (L01EX01) sunitinib (adm: O) | SUNITINIB VIPHARM | 50MG, 50MG CPS DUR 30 , TBC | Retail price with vat |
$0-0 |
$0-0 |
n/a | VipharmS.A.,OżarówMazowiecki |
| Czech Republic | (L04AC05) ustekinumab (adm: P) | OTULFI | 130MG, 130MG INF CNC SOL 1X26ML , VIA | Retail price with vat |
$0-0 |
$0-0 |
Crohn Disease;Colitis, Ulcerative | FreseniusKabiDeutschlandGmbH,BadHomburg |
| Czech Republic | (L04AC05) ustekinumab (adm: P) | OTULFI | 45MG, 45MG INJ SOL ISP 1X0,5ML , ISP | Retail price with vat |
$0-0 |
$0-0 |
Crohn Disease;Colitis, Ulcerative | FreseniusKabiDeutschlandGmbH,BadHomburg |
| Czech Republic | (L04AC05) ustekinumab (adm: P) | OTULFI | 90MG, 90MG INJ SOL ISP 1X1ML , ISP | Retail price with vat |
$0-0 |
$0-0 |
Crohn Disease;Colitis, Ulcerative | FreseniusKabiDeutschlandGmbH,BadHomburg |
| Czech Republic | (L04AD01) ciclosporin | EQUORAL | 100MG/ML, 100MG/ML POR SOL 1X50ML , LAG | Retail price with vat |
$0-0 |
$0-0 |
n/a | TevaB.V.,Haarlem |
| Czech Republic | (L04AD01) ciclosporin | EQUORAL | 100MG/ML, 100MG/ML POR SOL 1X50ML , LAG | Retail price with vat |
$0-0 |
$0-0 |
n/a | TevaB.V.,Haarlem |
| Czech Republic | (L04AE01) fingolimod (adm: O) | FIMODIGO | 0,5MG, 0,5MG CPS DUR 28 , BLI | Retail price with vat |
$0-0 |
$0-0 |
n/a | VipharmS.A.,OżarówMazowiecki |
| Czech Republic | (L04AE01) fingolimod (adm: O) | FINGOLIMOD RICHTER | 0,5MG, 0,5MG CPS DUR 28 , BLI | Retail price with vat |
$0-0 |
$0-0 |
n/a | GedeonRichterPlc.,Budapešť |
| Czech Republic | (M09AX09) onasemnogene abeparvovec | ZOLGENSMA | 2X10^13VG/ML, 2X10^13VG/ML INF SOL 1X5,5ML+12X8,3ML , VIA | Ex-factory price without vat |
$0-0 |
$0-0 |
Muscular Atrophy, Spinal | NovartisEuropharmLimited,Dublin |
| Czech Republic | (M09AX09) onasemnogene abeparvovec | ZOLGENSMA | 2X10^13VG/ML, 2X10^13VG/ML INF SOL 1X5,5ML+13X8,3ML , VIA | Ex-factory price without vat |
$0-0 |
$0-0 |
Muscular Atrophy, Spinal | NovartisEuropharmLimited,Dublin |
| Czech Republic | (M09AX09) onasemnogene abeparvovec | ZOLGENSMA | 2X10^13VG/ML, 2X10^13VG/ML INF SOL 1X5,5ML+2X8,3ML , VIA | Ex-factory price without vat |
$0-0 |
$0-0 |
Muscular Atrophy, Spinal | NovartisEuropharmLimited,Dublin |
| Czech Republic | (M09AX09) onasemnogene abeparvovec | ZOLGENSMA | 2X10^13VG/ML, 2X10^13VG/ML INF SOL 1X5,5ML+3X8,3ML , VIA | Ex-factory price without vat |
$0-0 |
$0-0 |
Muscular Atrophy, Spinal | NovartisEuropharmLimited,Dublin |
| Czech Republic | (M09AX09) onasemnogene abeparvovec | ZOLGENSMA | 2X10^13VG/ML, 2X10^13VG/ML INF SOL 1X5,5ML+4X8,3ML , VIA | Ex-factory price without vat |
$0-0 |
$0-0 |
Muscular Atrophy, Spinal | NovartisEuropharmLimited,Dublin |
| Czech Republic | (M09AX09) onasemnogene abeparvovec | ZOLGENSMA | 2X10^13VG/ML, 2X10^13VG/ML INF SOL 1X5,5ML+5X8,3ML , VIA | Ex-factory price without vat |
$0-0 |
$0-0 |
Muscular Atrophy, Spinal | NovartisEuropharmLimited,Dublin |
| Czech Republic | (M09AX09) onasemnogene abeparvovec | ZOLGENSMA | 2X10^13VG/ML, 2X10^13VG/ML INF SOL 1X5,5ML+6X8,3ML , VIA | Ex-factory price without vat |
$0-0 |
$0-0 |
Muscular Atrophy, Spinal | NovartisEuropharmLimited,Dublin |
| Czech Republic | (M09AX09) onasemnogene abeparvovec | ZOLGENSMA | 2X10^13VG/ML, 2X10^13VG/ML INF SOL 1X5,5ML+7X8,3ML , VIA | Ex-factory price without vat |
$0-0 |
$0-0 |
Muscular Atrophy, Spinal | NovartisEuropharmLimited,Dublin |
Pages
